Rapt TherapeuticsRAPT 13F holders, Q2 2025 (June 30) 48 holders
2 famous investors
$8.00 avg. 13F price*
At the end of Q2 2025 , 48 institutions reported holding Rapt Therapeutics Inc. (RAPT) in their 13F filings. The largest holders were Medicxi Ventures Management (Jersey) Ltd ($22.4M), Orbimed Advisors LLC ($13.1M) and TCG Crossover Management, LLC ($13.1M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
Company Rapt Therapeutics Inc.
CUSIP 75382E208
Latest filing quarter Q4 2025 History Number of 13F holders
Total Exit/New Position Q2 2025 Institutions Total Value New Positions 48 $124.9M Exits 0 $0
Ownership 48 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ Medicxi Ventures Management (Jersey) Ltd 5.23% New 2,794,000 $22.4M Orbimed Advisors LLC 0.33% New 1,641,906 $13.1M TCG Crossover Management, LLC 1.50% New 1,636,275 $13.1M Foresite Capital Management VI LLC 7.03% New 1,562,500 $12.5M RTW Investments, LP 0.17% New 1,470,499 $11.8M BVF Inc. 0.33% New 1,154,692 $9.2M Nantahala Capital Management, LLC 0.54% New 951,613 $7.6M Vanguard Group Inc. 0.00% New 880,049 $7.0M ADAR1 Capital Management, LLC 1.03% New 783,217 $6.3M Deep Track Capital, LP 0.19% New 751,422 $6.0M Redmile Group, LLC 0.54% New 630,686 $5.0M FCPM III Services B.V. 0.93% New 440,176 $3.5M Perceptive Advisors LLC 0.06% New 183,890 $1.5M Geode Capital Management, LLC 0.00% New 140,059 $1.1M Acadian Asset Management LLC 0.00% New 91,075 $726K BlackRock, Inc. 0.00% New 89,849 $719K Euclidean Capital LLC 0.22% New 82,234 $658K Renaissance Technologies 0.00% New 62,473 $500K Two Sigma Investments, LP 0.00% New 43,621 $349K Superstring Capital Management LP 0.26% New 26,034 $208K Northern Trust Corp. 0.00% New 24,739 $198K Two Sigma Advisers, LP 0.00% New 23,673 $189K Millennium Management 0.00% New 22,424 $179K Goldman Sachs Group Inc. 0.00% New 22,266 $178K State Street Corp. 0.00% New 19,062 $152K Morgan Stanley 0.00% New 18,014 $144K Bridgeway Capital Management, LLC 0.00% New 15,625 $125K Royal Bank of Canada 0.00% New 14,438 $115K Gsa Capital Partners LLP 0.01% New 12,144 $97K Charles Schwab Investment Management Inc. 0.00% New 10,000 $80K Bank of America Corp. 0.00% New 6,913 $55K UBS Group AG 0.00% New 3,692 $30K Citigroup Inc. 0.00% New 2,135 $17K FMR LLC 0.00% New 1,936 $15K Tower Research Capital LLC (TRC) 0.00% New 1,918 $15K Wells Fargo & Company 0.00% New 1,229 $10K Russell Investments Group, Ltd. 0.00% New 1,080 $9K Cwm, LLC 0.00% New 702 $6K PNC Financial Services Group, Inc. 0.00% New 497 $4K JPMorgan Chase & Co. 0.00% New 324 $3K Federated Hermes, Inc. 0.00% New 136 $1K BNP Paribas Financial Markets 0.00% New 135 $1K Simplex Trading, LLC 0.00% New 197 $1K Nisa Investment Advisors, LLC 0.00% New 79 $632 EverSource Wealth Advisors, LLC 0.00% New 56 $448 Barclays PLC 0.00% New 22 $176 Essential Partners LLC 0.00% — 1 $8 Amalgamated Bank 0.00% New 1 $0
"% of holder's portfolio" is RAPT's weight in each manager's 13F, not the share of Rapt Therapeutics Inc. the manager owns.